Black Sox, Ohtani’s interpreter and more: A look at notable sports betting scandals

In 1920, a Chicago grand jury indicted eight members of the Chicago White Sox on charges of fixing the 1919 World Series, an event that became notorious as the “Black Sox Scandal.” White Sox owner Charles Comiskey immediately suspended the eight players, including “Shoeless” Joe Jackson. A year later, they were permanently banned by newly appointed baseball Commissioner Kenesaw Mountain Landis. Although a jury returned a not guilty verdict on all charges, their ban from baseball stood until they were reinstated by Commissioner Rob Manfred in May 2025.

In 1946, Hockey Hall of Famer Babe Pratt was suspended for gambling but was reinstated weeks later. The NHL Board of Governors issued a warning that any further gambling incidents would lead to a lifetime suspension.

Two years later, in 1948, Billy Taylor and Don Gallinger received lifetime bans from the NHL for betting on hockey games.

In 1951, a major scandal erupted when 35 active and former players were accused of fixing at least 86 games spanning from 1947 to 1951. Among those implicated were four members of the Adolph Rupp-coached Kentucky Wildcats, accused of taking bribes from gamblers ahead of an NIT game against Loyola during the 1948-49 season. An NCAA investigation uncovered several violations, ultimately leading to the cancellation of Kentucky’s 1952-53 season.

The 1980 “Totonero” match-fixing scandal in Italian soccer resulted in the relegation of two teams and penalties for five others. Notably, Paolo Rossi was banned for two years due to his involvement while playing for Perugia.

In 1981, former Boston College basketball player Rick Kuhn and four others, including New York mobster Jimmy Burke, were convicted for conspiring to fix basketball games during the 1978-79 season.

Tulane University suspended its basketball program in 1985 amid point-shaving and other allegations. The program resumed play in the 1989-90 season.

Pete Rose, baseball’s all-time hits leader with 4,256 hits, agreed to a lifetime ban in 1989 after an MLB investigation found he bet on the Cincinnati Reds between 1985 and 1987 while serving as player and manager. Rose died in 2024 still ineligible for induction into Cooperstown, but in May 2025, Commissioner Rob Manfred changed MLB’s eligibility rules, clearing the path for Rose’s Hall of Fame consideration.

In 1996, thirteen Boston College football players were suspended for gambling, including two who bet against their own team in a 45-17 loss to Syracuse. Coach Dan Henning resigned after alerting school officials about the betting allegations. No evidence of point-shaving was found.

Philadelphia Flyers coach Rick Tocchet was placed on two years of probation in 2007 after pleading guilty to conspiracy and promoting gambling while serving as an assistant coach with the Phoenix Coyotes. He was reinstated by the NHL the following year. The investigation, known as “Operation Slapshot,” also implicated several players, Wayne Gretzky’s wife Janet Jones, and Gretzky’s former agent and then-Coyotes GM Michael Barnett.

In 2008, NBA referee Tim Donaghy pleaded guilty to wire fraud for transmitting inside betting information in exchange for thousands of dollars. He was sentenced to 15 months in federal prison.

Former Wales men’s rugby captain Rob Howley was suspended for 18 months in 2019 after it was revealed he made 363 bets, including on Wales’ Six Nations Grand Slam decider against Ireland. He was sent home on the eve of the Rugby World Cup where he was an assistant coach.

England defender Kieran Trippier was banned for 10 weeks in 2021 after providing insider information on his transfer to friends who then bet on the outcome.

At least 15 NFL players have been suspended for gambling violations since 1963. The earliest included Hall of Famers Paul Hornung and Alex Karras, who were suspended for betting on league games. Since 2022, at least 12 players have faced suspensions for betting. Notably, Atlanta Falcons receiver Calvin Ridley was banned for an entire season for betting on NFL games while away from the team for mental health reasons. Indianapolis Colts players Isaiah Rodgers Sr., Rashod Berry, and Demetrius Taylor were suspended indefinitely and released for betting on NFL games but were eventually reinstated.

In May 2023, Brazil’s lower house of Congress launched an investigation into a soccer match-fixing scandal involving players who allegedly secured bookings and penalties in exchange for bribes. This marked the third such probe in the country.

Six-time major champion golfer Phil Mickelson was alleged in 2023 to have wagered more than $1 billion over three decades, according to a book by gambler Billy Walters. Walters also claimed Mickelson intended to place a $400,000 bet on the 2012 Ryder Cup, which Mickelson denied, though he acknowledged his gambling crossed the line into addiction and has since stopped.

In 2023, soccer players Ivan Toney (Brentford), Sandro Tonali (Newcastle), and Nicolò Fagioli (Juventus) all served gambling bans. Fagioli received a seven-month ban from the Italian Soccer Federation, while Tonali was banned for 10 months the previous year for betting on teams he played for.

The NHL suspended Ottawa Senators forward Shane Pinto for 41 games in October 2023 due to sports gambling violations. The league clarified there was no evidence Pinto bet on hockey games. Pinto declined to comment when rejoining the Senators in January 2024.

In March 2024, the Los Angeles Dodgers fired Ippei Mizuhara, interpreter and close friend of star Shohei Ohtani, after reports surfaced of Mizuhara’s ties to an illegal bookmaker. Three months later, Mizuhara pleaded guilty to bank and tax fraud for stealing nearly $17 million from Ohtani’s account to cover gambling debts, baseball card purchases, and medical bills. He exploited language barriers to deceive Ohtani’s financial advisers and even impersonated Ohtani to the bank.

Toronto Raptors forward Jontay Porter was banned for life from the NBA in April 2024 following a league probe that found he disclosed confidential health information to sports bettors and wagered on games, including bets against his own team. Commissioner Adam Silver described Porter’s actions as “blatant.” The investigation uncovered a large $80,000 bet linked to Porter’s performance in a March 20 game against Sacramento, which could have paid out $1.1 million.

In June 2024, San Diego Padres infielder Tucupita Marcano became the first active MLB player banned for life in over a century after being discovered to have placed 387 bets totaling more than $150,000 with a legal sportsbook in 2022 and 2023. Additionally, Oakland Athletics pitcher Michael Kelly received a one-year suspension for baseball betting in the minor leagues. Three other minor leaguers—San Diego’s Jay Groome, Arizona’s Andrew Saalfrank, and Philadelphia’s José Rodríguez—also received one-year bans for betting on major league games, each wagering less than $1,000. Saalfrank and Rodríguez had prior major league experience.

In February 2025, MLB umpire Pat Hoberg was fired for sharing his legal sports gambling accounts with a friend who bet on baseball and for deleting electronic messages relevant to the league’s investigation. While no evidence showed Hoberg personally bet on games or manipulated outcomes, his friend made 141 baseball bets, including eight involving games Hoberg umpired. MLB senior vice president Michael Hill recommended the firing, with Commissioner Manfred upholding the decision. Hoberg, known as one of the best strike zone umpires, is eligible to apply for reinstatement no earlier than spring training 2026.

In June and July 2025, MLB placed Cleveland Guardians pitchers Luis Ortiz and Emmanuel Clase on paid leave amid a sports betting investigation. Ortiz was linked to unusual betting activity on specific pitches during games in Seattle and St. Louis. Clase was placed on leave three weeks later. On November 9, both were indicted on charges of accepting bribes to provide bettors with advance notice of pitch types and intentionally throwing balls instead of strikes to influence bets.

The NCAA announced in September 2025 it was investigating possible sports betting violations involving 13 former men’s basketball players from Eastern Michigan, Temple, Arizona State, New Orleans, North Carolina A&T, and Mississippi Valley. By November, six players had their eligibility revoked. The NCAA’s integrity monitoring and sources flagged suspicious text and social media messages revealing betting on and against their own teams, sharing information with bettors, outcome manipulation, and refusal to cooperate. In related cases, three players from Fresno State and San Jose State were found guilty of manipulating game outcomes and permanently lost eligibility.

In October 2025, a major gambling scandal unfolded involving 31 individuals, including Portland Trail Blazers coach Chauncey Billups, Miami Heat guard Terry Rozier, and former player and coach Damon Jones. Billups, the 2004 NBA Finals MVP, was charged with conspiracy to fix high-stakes card games connected to La Cosa Nostra organized crime families, resulting in at least $7 million in losses to unsuspecting gamblers. Rozier faced separate charges related to exploiting private player information to win NBA bets, alongside money laundering and wire fraud conspiracy charges. Damon Jones was implicated in both schemes and has pleaded not guilty.
https://mymotherlode.com/sports/college-sports-general-news/10165019/black-sox-ohtanis-interpreter-and-more-a-look-at-notable-sports-betting-scandals-2.html

Pfizer wins $10 billion bidding war for obesity drug developer

**Pfizer Clinches $10 Billion Deal for Obesity Drug Developer Metsera After Fierce Bidding War with Novo Nordisk**

U.S. drugmaker Pfizer has secured a $10 billion deal to acquire Metsera, an obesity drug developer, concluding an intense biotech bidding war against Danish rival Novo Nordisk. Metsera accepted Pfizer’s sweetened offer late Friday, citing U.S. antitrust risks in Novo’s bid despite previously considering it superior. Following this, Novo Nordisk announced on Saturday that it would exit the race.

### Pfizer’s Strategic Entry into the Obesity Drug Market

The acquisition gives Pfizer a valuable foothold in the lucrative obesity drug market, even though Metsera’s treatments are still years away from commercialization. This represents a setback for Novo Nordisk as it strives to regain ground lost to U.S. competitor Eli Lilly.

### A Dynamic and Twisting Bidding War

Initially, Pfizer appeared to have locked in the deal in September. However, last week Novo Nordisk jumped in with an unsolicited offer, sparking a heated fight for the coveted asset in the growing weight-loss sector. Pfizer aims to establish a presence in obesity treatments to overcome previous challenges in developing weight-loss drugs internally.

Pfizer agreed to pay $86.25 per share in cash — a 3.69% premium over Metsera’s Friday closing price. This price includes $65.60 per share in cash and a contingent value right, allowing shareholders to receive up to an additional $20.65 per share in cash.

Novo Nordisk confirmed on Saturday it would not increase its offer. “Following a competitive process and after careful consideration, Novo Nordisk will not increase its offer to acquire Metsera,” the company stated.

Novo added that it is advancing its own obesity treatment pipeline and will continue exploring business development and acquisition opportunities aligned with its strategic objectives. According to a source close to Novo, their last bid represented the “maximum value” of Metsera, and the firm remains confident in its own pipeline. The deal was never “do or die” for Novo, described as a “bolt-on acquisition” rather than a core strategic imperative.

### Antitrust Concerns Influence Decision

The bidding battle sent Metsera’s share price soaring over the past week, rising nearly 60% from just before Novo’s offer through Friday’s close, boosting its market value to $8.75 billion. At one point, Novo looked like the frontrunner in the bidding process.

However, Metsera cited concerns over “unacceptably high legal and regulatory risks” with Novo’s proposal, referencing a U.S. Federal Trade Commission (FTC) call discussing potential antitrust issues. Earlier in the week, the FTC sent a letter warning that a deal between Novo and Metsera could contravene U.S. antitrust laws. Novo, however, maintained that the structure of its offer complied with antitrust regulations.

Pfizer expressed satisfaction with reaching the revised agreement and anticipates closing the merger shortly after Metsera’s shareholder meeting scheduled for November 13.

### Analysts Weigh In: A ‘Game of Thrones’ Style Bidding War

Bernstein analyst Courtney Breen noted that the $10 billion price tag rests on optimistic assumptions about Metsera’s future performance. She highlighted that Pfizer would need to realize $11 billion in revenue from Metsera by 2040—nearly double Metsera’s present projections. Growing skepticism around the long-term pricing of GLP-1 drugs could also compress future margins.

Metsera’s board has recommended shareholders approve the amended Pfizer offer. Currently, Metsera is operating at a loss, and analysts expect continued losses while its drugs remain in development.

The bidding war raised the deal’s value well above Pfizer’s initial $7.3 billion offer in September. Former Pfizer R&D chief John LaMattina compared the fight to Pfizer’s historic $90 billion hostile takeover of Warner-Lambert in 2000, aimed at gaining control of the blockbuster cholesterol drug Lipitor. “While this is a smaller deal, Pfizer must believe that Metsera’s pipeline is key for its future,” he said.

Analysts and investors pointed to the fierce competition over Metsera, whose early-stage obesity drugs remain unproven but could play a pivotal role in a market projected to reach $150 billion by the early 2030s.

Peter Kolchinsky, managing partner at RA Capital and a top 20 Metsera shareholder, described the contest as “Game of Thrones-level” before Pfizer’s winning bid was accepted.

### Metsera’s Experimental Pipeline

Metsera’s main investigational obesity drugs include MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin. These two treatments are projected by Leerink Partners analyst David Risinger to reach combined peak sales of $5 billion.

Pfizer’s acquisition of Metsera marks a significant move in the expanding obesity drug marketplace, positioning the company to compete more aggressively in this rapidly growing sector.
https://nypost.com/2025/11/08/business/pfizer-wins-10-billion-bidding-war-for-metsera-over-novo-nordisk/

John Schneider explains controversial decision to keep Kevin Gausman in Game 2 after Will Smith home run

The Los Angeles Dodgers returned to baffling opponents with brilliant pitching in Game 2 of the World Series. Yoshinobu Yamamoto threw his second straight complete game of the postseason on Saturday, helping the Dodgers tie the series.

Yamamoto’s outstanding performance overshadowed a strong start from Kevin Gausman. The Toronto Blue Jays ace managed to match Yamamoto frame for frame through six innings, turning Game 2 into a true pitchers’ duel.

The Dodgers finally broke through in the seventh inning with solo home runs by Will Smith and Max Muncy. LA’s 3-1 lead proved to be more than enough for a dialed-in Yamamoto, who closed out the game brilliantly.

However, some Blue Jays fans questioned manager John Schneider’s decision to leave Gausman in the game to face the Dodgers’ lineup for the third time, especially after Smith’s 404-foot homer.

“We try to really take that into consideration. Got Shohei [for the third time in the sixth inning],” Schneider explained, according to TSN. “I think at that point it’s just game state. So I trusted Kev to get out of that. Even though it’s his third time. You kinda watch what he’s doing.”

Gausman started the seventh inning by retiring Freddie Freeman. He then faced Will Smith, who worked the count to full before Gausman threw six straight fastballs. Smith clobbered the final four-seamer into the second deck in left field, giving Los Angeles a 2-1 lead.

At this point, Gausman had thrown 72 pitches. Schneider chose to keep the two-time All-Star in the game, and Gausman struck out Teoscar Hernandez swinging. But he wouldn’t escape the inning unscathed, as Max Muncy belted another fastball deep to left field, extending the Dodgers’ lead to 3-1.

Louis Varland relieved Gausman and retired Kike Hernandez to end the seventh inning. Although Varland ran into some trouble the following inning as LA extended its lead further to 5-1, Schneider’s decision to leave Gausman in against Muncy did not ultimately change the outcome.

Yamamoto only needed a one-run lead as he mowed down 20 straight Blue Jays to close out his complete game. Meanwhile, Gausman had found a groove earlier in Game 2. After Smith’s RBI single in the first inning, the 34-year-old starter retired 17 consecutive Dodgers before Smith’s seventh-inning home run ended the streak.

Yamamoto and Gausman made history as the first starters to retire 17+ straight batters in a postseason game, highlighting the exceptional pitching duel that defined Game 2 of the World Series.
https://clutchpoints.com/mlb/toronto-blue-jays/blue-jays-news-john-schneider-kevin-gausman-game-2-will-smith-home-run

Our Fault OTT release: When and Where to watch Gabriel Guevara-Nicole Wallace’s romance flick in India?

**Our Fault OTT Release: The Final Installment of the Culpables Saga Premieres Today**

The much-anticipated third installment of the Spanish romance drama series, **Culpa Nuestra**, is set to release very soon. Known as **Our Fault** in its English version, this film marks the final chapter of the popular **Culpables** saga. Starring **Gabriel Guevara** and **Nicole Wallace**, the trilogy is based on Mercedes Ron’s bestselling book series of the same name.

Fans of the series have been eagerly awaiting the finale since last year, and now the wait is finally over. **Culpa Nuestra** will premiere today, on **16 October 2023**, exclusively on **Amazon Prime Video**.

### Our Fault’s Cast

Nicole Wallace and Gabriel Guevara return as the main leads, reprising their roles as **Noah Morán** and **Nicholas ‘Nick’ Leister**, respectively. Alongside them, several beloved characters make a comeback, including **Marta Hazas**, **Iván Sánchez**, **Víctor Varona**, and **Eva Ruiz**.

This third chapter also introduces fresh faces to the saga. New cast members such as **Goya Toledo**, **Gabriela Andrada**, **Álex Béjar**, **Javier Morgade**, **Felipe Londoño**, and **Fran Morcillo** join the original ensemble, promising to bring new dynamics to the story.

### Plot and Storyline of Our Fault

The **Culpables** saga centers around the heartfelt and intense relationship between two young individuals struggling to move on from their traumatic pasts. In this final installment, Nick emerges as a powerful business heir wrestling with his lingering anger issues, while Noah focuses on personal growth and furthering her career.

**Culpa Nuestra** picks up the narrative from where **Culpa Tuya (Your Fault)** left off. Fans can expect familiar characters like **Brier** to stir up trouble once again. Adding to the intrigue is a new character named **Simon**, who is expected to add an extra layer of complexity to the plot.

While the on-screen ending may differ, readers of the novel know that the story concludes with a wedding. In the book, Noah reveals she is pregnant, a revelation that reunites her with Nick. Nick’s acceptance of fatherhood becomes a pivotal factor in their reconciliation.

As the film unfolds, audiences eagerly await to see how this beloved story will be adapted on screen and whether it will stay true to its literary roots.

Be sure to catch **Our Fault** on Amazon Prime Video starting **16 October 2023** and witness the emotional conclusion of the **Culpables** saga.
https://www.bollywoodlife.com/viral-stories/our-fault-ott-release-twhen-and-where-to-catch-the-gabriel-guevara-and-nicole-wallace-starrer-spanish-romance-drama-in-india-3266374/